Assessment of long-term alopecia after adjuvant taxane therapy for early breast cancer: a cross-sectional survey

    June 2025 in “ Supportive Care in Cancer
    Amy E. Smith, Michelle Harrison, Catriona M. McNeil, Jane Beith, Jennifer Lim
    The study assessed long-term alopecia in patients who underwent adjuvant taxane therapy for early breast cancer, revealing that docetaxel chemotherapy is linked to significantly higher rates of dissatisfaction and chronic alopecia compared to paclitaxel chemotherapy. These findings align with existing literature and highlight the importance of discussing potential alopecia risks with patients before starting docetaxel regimens.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results